Citadel Advisors - CELLULAR BIOMEDICINE GROUP I ownership

Back to all holdings Add to watchlist

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Citadel Advisors ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q3 2020$259,000
+28.9%
14,100
+11.0%
0.00%–
Q1 2020$201,000
+22.6%
12,700
+25.7%
0.00%–
Q4 2019$164,000
-12.8%
10,100
-2.6%
0.00%–
Q3 2018$188,000
+4.4%
10,368
-16.4%
0.00%–
Q3 2016$180,000–12,400–0.00%–
 Download
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders